The results of a new study suggest that people who have recovered from coronavirus may only need one dose of vaccine to develop the same degree of immunity as those who receive two doses.
Like the New York Times reports, Florian Krammer, study author and virologist at Mount Iinahn School of Medicine in Mount Sinai, said he believed a shot would be enough for people who have already been hired and recovered from COVID-19 .
“This would also save individuals from unnecessary pain when receiving the second dose and would release additional doses of vaccine,” Krammer said.
The Krammer study found that coronavirus survivors had much higher antibody levels after receiving two doses of the vaccine compared to those who did not get COVID-19. The study of 231 vaccinated people included 83 who had contracted the virus.
The study also found that people who previously had the coronavirus were more likely to experience unpleasant symptoms such as headaches, muscle aches and chills after receiving the first dose of vaccine.
While some scientists agree with Krammer’s claim, others are unconvinced, the Times notes.
The director of the Institute of Immunology at the University of Pennsylvania, E. John Wherry, told the newspaper that he would like to see data suggesting that the antibodies observed in the study would prevent coronavirus reproduction.
“Just because an antibody binds to a part of the virus doesn’t mean it protects you from infection,” Wherry said.
Some health officials have argued that the U.S. should prioritize the first vaccine vaccine in as many arms as possible.
But Anthony Fauci
Anthony FauciBloomberg: More Americans have received at least one dose of COVID-19 vaccine that has tested positive for Biden officials who advocate the two-dose strategy amid fears of variants., the country’s leading infectious disease expert, has said a second dose should be given priority.
“The first priority will always be to get people who have received the first doses to get their second dose,” Fauci said.
The Biden administration has argued that two doses of the vaccine should be administered, although it has also urged health care providers not to be too cautious in maintaining vaccine dose reserves.